Allogene Therapeutics: Still Looking Shaky, But Looking To Turn The Corner (Rating Upgrade)

Core Insights - The article expresses cautious optimism regarding Allogene Therapeutics, highlighting the company's ongoing early-stage development efforts [1] Company Analysis - Allogene Therapeutics is currently in the early stages of development, which may present both opportunities and challenges for investors [1] Industry Context - The article emphasizes the importance of understanding the science behind biotech investments, suggesting that thorough due diligence is essential for avoiding potential pitfalls in this sector [1]